✦ LIBER ✦

AS-218 Comparison of Resolute zotarolimus-eluting stent and Sirolimus-Eluting Stents in Patients with Long Coronary Artery Lesions: A Randomized LONG-DES IV Trial

✍ Scribed by Jung-Min Ahn; Hae-Geun Song; Jong-Young Lee; Won-Jang Kim; Duk-Woo Park; Soo-Jin Kang; Seung-Whan Lee; Young-Hak Kim; Cheol-Whan Lee; Seong-Wook Park; Seung-Jung Park

Book ID: 113448963
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 303 KB
Volume: 109
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2012.01.252

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

AS-157: Comparison of Zotarolimus-Elutin

AS-157: Comparison of Zotarolimus-Eluting Stents with Sirolimus-Eluting and Paclitaxel-Eluting Stents for Patients with Diabetes Mellitus in the ZEST Trial: A Subanalysis of a Randomized Trial

✍ Jong-Sun Park; Duk-Woo Park; Young-Hak Kim; Sung-Cheol Yun; Soo-Jin Kang; Seung- 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 133 KB

SPIRIT IV trial design: A large-scale ra

SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease

✍ Eugenia Nikolsky; Alexandra J. Lansky; Krishnankutty Sudhir; Julie Doostzadeh; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 305 KB

SIROLIMUS ELUTING STENT WITH BIODEGRADAB

SIROLIMUS ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS ELUTING STENT WITH DURABLE POLYMER FOR THE TREATMENT OF PATIENTS WITH DE NOVO CORONARY ARTERY LESIONS (EVOLUTION): A RANDOMIZED NON-INFERIORITY TRIAL

✍ Junbo Ge; Lei Ge; Juying Qian; Guosheng Fu; Huiliang Liu; Genshan Ma; Yitong Ma; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Sirolimus-eluting stents for treatment o

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS)

✍ J Schofer; M Schlüter; A.H Gershlick 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB